A case of reversible cerebral vasoconstriction syndrome associated with anti-phospholipid antibody syndrome and systemic lupus erythematosus.

Shima, Atsushi; Maki, Takakuni; Mimura, Naoya; Yamashita, Hirofumi; Emoto, Noriaki; Yoshifuji, Hajime; Takahashi, Ryosuke

Shima, Atsushi; Maki, Takakuni; Mimura, Naoya; Yamashita, Hirofumi; Emoto, Noriaki; Yoshifuji, Hajime; Takahashi, Ryosuke.

Afiliación

Shima A; Department of Neurology, Kyoto University Graduate School of Medicine, Japan.
Maki T; Department of Neurology, Kyoto University Graduate School of Medicine, Japan.
Mimura N; Department of Neurology, Kyoto University Graduate School of Medicine, Japan.
Yamashita H; Department of Neurology, Kyoto University Graduate School of Medicine, Japan.
Emoto N; Laboratory of Clinical Pharmaceutical Science, Kobe Pharmaceutical University, Japan.
Yoshifuji H; Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Japan.
Takahashi R; Department of Neurology, Kyoto University Graduate School of Medicine, Japan.

eNeurologicalSci ; 24: 100351, 2021 Sep.

Article en En | MEDLINE | ID: mdl-34258413

Palabras clave

Anti-phospholipid antibody syndrome; Cilostazol; Endothelin-1; Lomerizine; Reversible cerebral vasoconstriction syndrome

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: ENeurologicalSci Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google